Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Molecular Pharmacology|November 20, 2012
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificityGemma L Baillie, James G Horswill, Sharon Anavi-Goffer, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levelsDaniel K Nomura, Carolyn S S Hudak, Anna M Ward, et al.ACS Medicinal Chemistry Letters|January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity RelationshipLaura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.The Journal of Biological Chemistry|July 2, 2013
Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55Justine Yu, Elena Deliu, Xue-Quian Zhang, et al.Bioorganic & Medicinal Chemistry|July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonistsLara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.Biochemistry|May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.Bioorganic & Medicinal Chemistry Letters|February 27, 2016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesMaria Elena Meza-Aviña, Mary A Lingerfelt, Linda M Console-Bram, et al.Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.Pageof 8